Nasdaq
FDMT
4D Molecular Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +2.6%
- 1 month
- −17.7%
- 1 year
- +84.1%
$10.55 · Mkt cap $552M
At the 6 Aug 2026 close
Nasdaq
4D Molecular Therapeutics, Inc.
$10.55 · Mkt cap $552M
At the 6 Aug 2026 close
4D Molecular Therapeutics, Inc. trades under the ticker FDMT on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $552M. The last closing price was $10.55, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +84.1%, and −17.7% over the past month. Returns are price returns and exclude dividends.
This page exists because FDMT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.